• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
FDA Core Presentations, (BLA) 125370, BENLYSTA (belimumab) for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee
 
Introduction:
Badrul Chowdhury, M.D., Ph.D., Director, Division of Pulmonary, Allergy and Rheumatology Products (DPARP), Office of Drug Evaluation (ODE) II, Office of New Drugs (OND), CDER, FDA (PDF - 70KB)
 
Main Presentation:
Rosemarie Neuner, M.D., Clinical Reviewer, DPARP, ODE II, OND, CDER, FDA; Ruthanna Davi, Ph.D., Statistical Reviewer, Division of Biometrics II, Office of Biostatistics, Office of Translational Science, CDER, FDA (PDF – 908KB)
                            
 
 
Sponsor
 
 
Human Genome Sciences Core Presentations, (BLA) 125370, BENLYSTA (belimumab) for the November 16, 2010 Meeting of the Arthritis Drugs Advisory Committee (PDF – 4.6MB)
 
Human Genome Sciences, Backup Presentation Slides Shown (PDF – 5.9MB)